Labeled for this condition
Medicines for seizures and epilepsy
27 medicines have an FDA label indicated for seizures and epilepsy; 25 are listed from generic labelers and 1 has a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for seizures and epilepsy?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Gabapentin | Neurontin, Gralise, Relgaabi | 85 labelers | $0.0218 per capsule 100 mg capsule | No | No current entry | 22 |
| Pregabalin | Lyrica | 52 labelers | $0.0571 per capsule 100 mg capsule | No | No current entry | 5 |
| Levetiracetam | Keppra, Spritam, Elepsia | 84 labelers | $0.0736 per tablet 500 mg tablet | No | No current entry | 15 |
| Lamotrigine | Lamictal, Subvenite | 49 labelers | $0.0268 per tablet 25 mg tablet | Yes | A presentation being discontinued | 10 |
| Topiramate | Topamax, Qudexy, Trokendi | 47 labelers | $0.0567 per tablet 100 mg tablet | No | No current entry | 10 |
| Phenobarbital | Sezaby | none listed | $0.213 per tablet 100 mg tablet | No | A presentation being discontinued | 9 |
| Divalproex | Depakote | 44 labelers | $0.194 per tablet 500 mg tablet | Yes | No current entry | 16 |
| Lacosamide | Vimpat, Motpoly | 57 labelers | $0.174 per tablet 100 mg tablet | No | No current entry | 8 |
| Carbamazepine | Tegretol, Carbatrol, Equetro | 42 labelers | $0.119 per tablet 200 mg tablet | Yes | A presentation being discontinued | 11 |
| Clonazepam | Klonopin | 31 labelers | $0.0244 per tablet 1 mg tablet | Yes | In shortage | 7 |
| Magnesium sulfate | none listed | 17 labelers | $0.0039 per gram Epsom salt | No | No current entry | 10 |
| Oxcarbazepine | Trileptal, Oxtellar | 43 labelers | $0.167 per tablet 300 mg tablet | No | No current entry | 6 |
| Everolimus | Afinitor, Zortress, Torpenz | 14 labelers | $26.32 per tablet 10 mg tablet | No | A presentation being discontinued | 5 |
| Brivaracetam | Briviact | 16 labelers | $0.259 per tablet 100 mg tablet | No | No current entry | 1 |
| Phenytoin | Dilantin, Phenytek | 29 labelers | $0.145 per capsule 100 mg capsule | No | No current entry | 11 |
| Valproic acid | none listed | 22 labelers | $0.243 per capsule 250 mg capsule | Yes | Listed; available | 2 |
| Zonisamide | Zonegran | 20 labelers | $0.106 per capsule 100 mg capsule | No | No current entry | 11 |
| Primidone | Mysoline | 21 labelers | $0.0914 per tablet 50 mg tablet | No | No current entry | 6 |
| Eslicarbazepine | Aptiom | 9 labelers | $1.68 per tablet 200 mg tablet | No | No current entry | 0 |
| Perampanel | Fycompa | 3 labelers | $14.43 per tablet 4 mg tablet | Yes | No current entry | 1 |
| Clorazepate | none listed | 8 labelers | $0.524 per tablet 3.75 mg tablet | Yes | No current entry | 2 |
| Felbamate | Felbatol | 9 labelers | $1.00 per tablet 600 mg tablet | Yes | No current entry | 0 |
| Fosphenytoin | Cerebyx | 7 labelers | n/a | Yes | No current entry | 6 |
| Ethosuximide | Zarontin | 9 labelers | $0.243 per capsule 250 mg capsule | No | No current entry | 4 |
| Cenobamate | Xcopri | none listed | $39.87 per tablet 100 mg tablet | No | No current entry | 0 |
| Tiagabine | none listed | 2 labelers | $2.62 per tablet 2 mg tablet | No | A presentation being discontinued | 1 |
| Methsuximide | Celontin | 1 labeler | $4.40 per capsule 300 mg capsule | No | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price